Superworth

InnovAge free cash flow INNV

Cash from operations less capital spending, by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
$50.4M
Latest quarter, Q4 FY26
$17M
+85% on a year earlier
Fiscal year 2026
$50.4M
+89% on the year before

InnovAge's free cash flow was $50.4M over the twelve months to Jun 30, 2026, up 89% on a year earlier.

In its latest quarter, Q4 FY26, it was $17M, up 85% on the same quarter a year before.

Free cash flow over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearFree cash flowChange
FY2026$50.4M+89%
FY2025$26.6Mn/a
FY2024−$44.8Mn/a
FY2023−$3.1Mn/a
FY2022−$10.9Mn/a
FY2021−$25.1Mn/a
FY2020n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedFree cash flowOn a year earlierLast 12 months
Q4 FY26$17M+85%$50.4M
Q3 FY26$14.5M−33%$42.6M
Q2 FY26$19M+251%$49.8M
Q1 FY26−$153Kn/a$36.2M
Q4 FY25$9.2Mn/a$26.6M
Q3 FY25$21.7M+611%$16M
Q2 FY25$5.4Mn/a−$2.7M
Q1 FY25−$9.7Mn/a−$19M
Q4 FY24−$1.4M−116%−$44.8M
Q3 FY24$3.1M−87%−$34.3M
Q2 FY24−$10.9Mn/a−$12.9M
Q1 FY24−$35.6M−751%−$44.1M

Against its peers

Companies in Medical - Care Facilities nearest InnovAge's size, closest first, today.

Where InnovAge ranks

What the free cash flow tells you

Cash from operations minus capital spending. The cash the company could hand back or reinvest.

Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.

More on InnovAge

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.